Two series of 3‐[(1‐benzyl‐1H‐1,2,3‐triazol‐4‐yl)methyl]quinazolin‐4(3H)‐ones and N‐(1‐benzylpiperidin‐4‐yl)quinazolin‐4‐amines were designed initially as potential acetylcholine esterase inhibitors. Biological evaluation demonstrated that N‐(1‐benzylpiperidin‐4‐yl)quinazolin‐4‐amines significantly inhibited AChE activity. Especially, two compounds of them were found to be the most potent with relative AChE inhibition percentages of 87 % in comparison to donepezil. The docking studies with AChE showed similar interactions between donepezil and four derivatives. N‐(1‐Benzylpiperidin‐4‐yl)quinazolin‐4‐amines also exhibited significant DPPH scavenging effects. The two series of compound also exerted moderate to good cytotoxicity against three human cancer cell lines, including SW620 (human colon cancer), PC‐3 (prostate cancer), and NCI−H23 (lung cancer), with 3‐[(1‐benzyl‐1H‐1,2,3‐triazol‐4‐yl)methyl]quinazolin‐4(3H)‐one being the most cytotoxic agent. 3‐[(1‐Benzyl‐1H‐1,2,3‐triazol‐4‐yl)methyl]quinazolin‐4(3H)‐one significantly induced early apoptosis and arrested the SW620 cells at G2/M phase. From this study, two compounds of N‐(1‐benzylpiperidin‐4‐yl)quinazolin‐4‐amines could serve as new leads for further design and AChE inhibitors, while 3‐[(1‐benzyl‐1H‐1,2,3‐triazol‐4‐yl)methyl]quinazolin‐4(3H)‐one could serve as a new lead for the design and development of more potent anticancer agents.

中文翻译：

---

两个系列的 3-((1-Benzyl-1H-1,2,3-triazol-4-yl)methyl)quinazolin-4(3H)-ones 和 N-(1-benzylpiperidin-4) 的设计、合成和生物评价-基)喹唑啉-4-胺

两个系列的 3-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]quinazolin-4(3H)-ones 和 N-(1-benzylpiperidin-4-yl)quinazolin-4 - 胺最初被设计为潜在的乙酰胆碱酯酶抑制剂。生物学评估表明，N-(1-benzylpiperidin-4-yl)quinazolin-4-amines 显着抑制 AChE 活性。特别是，与多奈哌齐相比，发现其中的两种化合物最有效，相对 AChE 抑制百分比为 87%。与 AChE 的对接研究显示多奈哌齐和四种衍生物之间的相互作用相似。N-(1-Benzylpiperidin-4-yl)quinazolin-4-amines 也表现出显着的 DPPH 清除作用。这两个系列的化合物还对三种人类癌细胞系，包括 SW620（人类结肠癌）、PC-3（前列腺癌）、和 NCI-H23（肺癌），其中 3-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]quinazolin-4(3H)-one 是最具细胞毒性的药物。3-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]quinazolin-4(3H)-one 显着诱导早期细胞凋亡并在 G2/M 期阻止 SW620 细胞。从这项研究中，N-(1-benzylpiperidin-4-yl)quinazolin-4-amines 的两种化合物可以作为进一步设计和 AChE 抑制剂的新线索，而 3-[(1-benzylpiperidin-1H-1,2, 3-triazol-4-yl)methyl]quinazolin-4(3H)-one 可以作为设计和开发更有效的抗癌药物的新线索。